Page last updated: 2024-09-05

sb 203580 and ha 1004

sb 203580 has been researched along with ha 1004 in 2 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(ha 1004)
Trials
(ha 1004)
Recent Studies (post-2010) (ha 1004)
3,48941,13723406

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M1
Sharp, PA; Tang, H1

Other Studies

2 other study(ies) available for sb 203580 and ha 1004

ArticleYear
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

    Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007
Transcriptional regulation of the murine 3' IgH enhancer by OCT-2.
    Immunity, 1999, Volume: 11, Issue:5

    Topics: 3' Untranslated Regions; Alleles; Animals; B-Lymphocytes; Cyclic AMP-Dependent Protein Kinases; DNA; DNA-Binding Proteins; Enhancer Elements, Genetic; Enzyme Inhibitors; Gene Expression Regulation; Genistein; Imidazoles; Immunoglobulin Heavy Chains; Isoquinolines; Lipopolysaccharides; Lymphocyte Activation; Mice; Mice, Knockout; Mutagenesis, Site-Directed; Octamer Transcription Factor-2; Phosphorylation; Protein Binding; Protein Kinase C; Protein Processing, Post-Translational; Protein Structure, Tertiary; Pyridines; Recombinant Fusion Proteins; Staurosporine; Structure-Activity Relationship; Sulfonamides; Trans-Activators; Transcription Factors; Transcriptional Activation; Transfection

1999